Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Medicamen Biotech Ltd.
Swot
Medicamen Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Medicamen Biotech Ltd. has 9 Strengths, 20 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(9)
Weakness
(20)
Opportunity
(0)
Threats
(1)
Others
(7)
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Companies with high TTM EPS Growth
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
Relative Outperformance versus Industry over 1 Week
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Promoter decreasing their shareholding
PE higher than Industry PE
Promoter holding decreased by more than -2% QoQ
High PE (PE > 40)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Declining profits every quarter for the past 2 quarters
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Near 52 Week Low
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Declining profitability: Falling ROCE
Stocks Underperforming their Industry Price Change in the Quarter
Insiders sold stocks
Rising Delivery Percentage Compared to Prev Day
Bullish or Bearish Candlestick Strength - Indices
Bullish Harami (Bullish Reversal)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Declining Net Cash Flow and Cash from Operating Activity for last 2 years
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
